MO50-3 Preliminary data from the phase I/II study of TP-3654, an oral PIM-1 kinase inhibitor, in patients with myelofibrosis
Firas El Chaer,Junichiro Yuda,James Mccloskey,Lindsay Rein,Randy Brown,Steven Green, Jeffrey Pu,Shuichi Shirane,Kazuya Shimoda,Michiko Ichii,Joseph Scandura,Sujan Kabir,Jason M. Foulks,Jian Mei,Huyuan Yang,Mark Wade,Carl Stapinski,Claudia Lebedinsky,Raajit K. Rampal Annals of Oncology（2023）
AI 理解论文
溯源树
样例
